Skip to main content

Spinal Muscular Atrophy clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

    Sorry, in progress, not accepting new patients

    This trial will study the efficacy and safety of taldefgrobep alfa as an adjunctive therapy for participants who are already taking a stable dose of nusinersen or risdiplam or have a history of onasemnogene abeparvovec-xioi, compared to placebo.

    San Francisco, California and other locations

Last updated: